These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 26037484)
1. The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial. Cockayne NL; Duffy SL; Bonomally R; English A; Amminger PG; Mackinnon A; Christensen HM; Naismith SL; Hickie IB Trials; 2015 Jun; 16():247. PubMed ID: 26037484 [TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial. Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916 [TBL] [Abstract][Full Text] [Related]
3. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Banerjee S; Hellier J; Romeo R; Dewey M; Knapp M; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A Health Technol Assess; 2013 Feb; 17(7):1-166. PubMed ID: 23438937 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402 [TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial. Duffy L; Bacon F; Clarke CS; Donkor Y; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Lewis G; Mangin D; Marston L; Moore M; Nazareth I; Wiles N; Lewis G Trials; 2019 Jun; 20(1):319. PubMed ID: 31159856 [TBL] [Abstract][Full Text] [Related]
7. Preventing depression after stroke: Results from a randomized placebo-controlled trial. Almeida OP; Waterreus A; Hankey GJ J Clin Psychiatry; 2006 Jul; 67(7):1104-9. PubMed ID: 16889454 [TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial. Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474 [TBL] [Abstract][Full Text] [Related]
9. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899 [TBL] [Abstract][Full Text] [Related]
10. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial. Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706 [TBL] [Abstract][Full Text] [Related]
11. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079 [TBL] [Abstract][Full Text] [Related]
12. Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease. Roest AM; Carney RM; Stein PK; Freedland KE; Meyer H; Steinmeyer BC; de Jonge P; Rubin EH J Clin Psychiatry; 2012 Jan; 73(1):31-6. PubMed ID: 21903027 [TBL] [Abstract][Full Text] [Related]
13. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749 [TBL] [Abstract][Full Text] [Related]
14. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185 [TBL] [Abstract][Full Text] [Related]
15. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. Keller MB; Kocsis JH; Thase ME; Gelenberg AJ; Rush AJ; Koran L; Schatzberg A; Russell J; Hirschfeld R; Klein D; McCullough JP; Fawcett JA; Kornstein S; LaVange L; Harrison W JAMA; 1998 Nov; 280(19):1665-72. PubMed ID: 9831997 [TBL] [Abstract][Full Text] [Related]
16. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol. Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974 [TBL] [Abstract][Full Text] [Related]
18. Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial. Lin CH; Wang SH; Lane HY Int J Neuropsychopharmacol; 2022 Aug; 25(7):545-555. PubMed ID: 35023557 [TBL] [Abstract][Full Text] [Related]
19. Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: protocol for a randomised, double-blind, placebo controlled trial. Cockayne NL; Glozier N; Naismith SL; Christensen H; Neal B; Hickie IB BMC Psychiatry; 2011 Jan; 11():10. PubMed ID: 21232162 [TBL] [Abstract][Full Text] [Related]